Bifunctional haptenization and dyed microparticles regulatory update

Xtrana received U.S. Patent No. 5,989,813 covering the visual or fluorescent detection of amplified target nucleic acid sequences using haptenized oligonucleotides. Xtrana is merging with Biopool Int...